Name: Federal Grants and Assistance Listings
Creator: US Federal Government
License: https://creativecommons.org/licenses/by/4.0/
Keywords: federal grants 2026, CFDA listings, SAM.gov assistance, grants.gov programs

Agency

Program Type

Reset

732 programs

PAR-25-158
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

🏛 National Institutes of Health Posted

Opportunity #: PAR-25-158. Agency: National Institutes of Health. Status: Posted. Closes: 11/17/2026. Posted: 11/25/2024.
PAR-25-281
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)

🏛 National Institutes of Health Posted

Opportunity #: PAR-25-281. Agency: National Institutes of Health. Status: Posted. Closes: 01/07/2028. Posted: 11/22/2024.
RFA-HL-26-019
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

🏛 National Institutes of Health Posted

Opportunity #: RFA-HL-26-019. Agency: National Institutes of Health. Status: Posted. Closes: 12/23/2027. Posted: 11/22/2024.
PAR-25-291
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)

🏛 National Institutes of Health Posted

Opportunity #: PAR-25-291. Agency: National Institutes of Health. Status: Posted. Closes: 01/07/2028. Posted: 11/22/2024.
PAR-25-282
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)

🏛 National Institutes of Health Posted

Opportunity #: PAR-25-282. Agency: National Institutes of Health. Status: Posted. Closes: 01/07/2028. Posted: 11/22/2024.
PAR-25-290
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)

🏛 National Institutes of Health Posted

Opportunity #: PAR-25-290. Agency: National Institutes of Health. Status: Posted. Closes: 01/07/2028. Posted: 11/22/2024.
RFA-HL-26-020
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

🏛 National Institutes of Health Posted

Opportunity #: RFA-HL-26-020. Agency: National Institutes of Health. Status: Posted. Closes: 12/23/2027. Posted: 11/22/2024.
RFA-HL-26-016
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

🏛 National Institutes of Health Posted

Opportunity #: RFA-HL-26-016. Agency: National Institutes of Health. Status: Posted. Closes: 12/23/2027. Posted: 11/22/2024.
PAR-25-226
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

🏛 National Institutes of Health Posted

Opportunity #: PAR-25-226. Agency: National Institutes of Health. Status: Posted. Closes: 11/19/2026. Posted: 11/22/2024.
RFA-HL-26-018
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

🏛 National Institutes of Health Posted

Opportunity #: RFA-HL-26-018. Agency: National Institutes of Health. Status: Posted. Closes: 12/23/2027. Posted: 11/22/2024.
RFA-HL-26-017
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

🏛 National Institutes of Health Posted

Opportunity #: RFA-HL-26-017. Agency: National Institutes of Health. Status: Posted. Closes: 12/23/2027. Posted: 11/22/2024.
PAR-25-274
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

🏛 National Institutes of Health Posted

Opportunity #: PAR-25-274. Agency: National Institutes of Health. Status: Posted. Closes: 11/17/2026. Posted: 11/21/2024.
PAR-25-268
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

🏛 National Institutes of Health Posted

Opportunity #: PAR-25-268. Agency: National Institutes of Health. Status: Posted. Closes: 11/17/2026. Posted: 11/21/2024.
PAR-25-286
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)

🏛 National Institutes of Health Posted

Opportunity #: PAR-25-286. Agency: National Institutes of Health. Status: Posted. Closes: 01/07/2028. Posted: 11/21/2024.
PAR-26-001
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)

🏛 National Institutes of Health Posted

Opportunity #: PAR-26-001. Agency: National Institutes of Health. Status: Posted. Closes: 05/07/2027. Posted: 11/21/2024.
PAR-25-267
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

🏛 National Institutes of Health Posted

Opportunity #: PAR-25-267. Agency: National Institutes of Health. Status: Posted. Closes: 11/17/2026. Posted: 11/21/2024.
PAR-25-248
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

🏛 National Institutes of Health Posted

Opportunity #: PAR-25-248. Agency: National Institutes of Health. Status: Posted. Closes: 10/08/2027. Posted: 11/21/2024.
PAR-25-148
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)

🏛 National Institutes of Health Posted

Opportunity #: PAR-25-148. Agency: National Institutes of Health. Status: Posted. Closes: 01/07/2028. Posted: 11/21/2024.
FOR-MH-26-165
Mechanistic Exploration of Therapeutic Targets and Treatable Traits to Improve CNS Outcomes in People with HIV

🏛 National Institutes of Health Forecasted

Opportunity #: FOR-MH-26-165. Agency: National Institutes of Health. Status: Forecasted Posted: 06/09/2025.
FOR-HG-25-020
Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)

🏛 National Institutes of Health Forecasted

Opportunity #: FOR-HG-25-020. Agency: National Institutes of Health. Status: Forecasted Posted: 06/06/2025.

Showing 241–260 of 732

‹ Prev 11 12 13 14 15 Next ›

💰 Federal Grants & Assistance Programs

Get Federal ContractingIntelligence — Free

Meeting Request Sent!

Don't Miss a Single Federal Contract

Get Federal Contracting
Intelligence — Free

Don't Miss a Single
Federal Contract